Rezolute (RZLT) Other Non-Current Liabilities (2014 - 2020)
Rezolute (RZLT) reported Other Non-Current Liabilities of $12000.0 for Q1 2020, down 57.89% on a YoY basis from $28499.0 in Q2 2019, and down 75.0% sequentially from $48000.0 in Q4 2019.
Rezolute (RZLT) Other Non-Current Liabilities (2014 - 2020) Analysis & Trends
Rezolute (RZLT) has 7 years of Other Non-Current Liabilities data on file, last reported at $12000.0 in Q1 2020.
- For the quarter ending Q1 2020, Other Non-Current Liabilities fell 57.89% year-over-year to $12000.0; the trailing twelve-month figure through Mar 2020 stood at $12000.0 (down 57.89% YoY), and the FY2019 full-year result was $121000.0, down 43.98% from the prior year.
- Other Non-Current Liabilities retreated to $12000.0 in Q1 2020, from $48000.0 in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $431341.0 in Q1 2016 to a low of $12000.0 in Q1 2020.
- A 5-year average of $221431.7 and a median of $229843.0 in 2017 frame the typical range for Other Non-Current Liabilities.
- Across the five-year window, Other Non-Current Liabilities soared 149.61% in 2016 and plunged 86.58% in 2019, its largest moves.
- Tracing RZLT's Other Non-Current Liabilities over 5 years: stood at $335588.0 in 2016, then fell by 27.39% to $243686.0 in 2017, then plunged by 39.17% to $148224.0 in 2018, then plunged by 67.62% to $48000.0 in 2019, then tumbled by 75.0% to $12000.0 in 2020.
- Business Quant data shows RZLT's Other Non-Current Liabilities at $12000.0 in Q1 2020, $48000.0 in Q4 2019, and $85000.0 in Q3 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Rezolute | 31,153.77 | 31,153.77 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | 12,000.00 |
| Dec 31, 2019 | 48,000.00 |
| Sep 30, 2019 | 85,000.00 |
| Jun 30, 2019 | 121,000.00 |
| Mar 31, 2019 | 28,499.00 |
| Sep 30, 2018 | 148,224.00 |
| Jun 30, 2018 | 216,000.00 |
| Mar 31, 2018 | 212,358.00 |
| Dec 31, 2017 | 243,686.00 |
| Sep 30, 2017 | 274,130.00 |
| Jun 30, 2017 | 304,575.00 |
| Mar 31, 2017 | 314,655.00 |
| Dec 31, 2016 | 335,588.00 |
| Sep 30, 2016 | 367,813.00 |
| Jun 30, 2016 | 400,038.00 |
| Mar 31, 2016 | 431,341.00 |
| Dec 31, 2015 | 460,794.00 |
| Sep 30, 2015 | 453,586.00 |
| Jun 30, 2015 | 480,490.00 |
| Mar 31, 2015 | 172,809.00 |